SettlementListSearch settlements

Twist Bioscience Securities Settlement

Published · Updated · SettlementList

Twist Bioscience Corporation settled allegations that it and two of its executives violated the federal securities laws by making false and misleading statements concerning Twist’s production process, product quality, and accounting, and regarding its internal controls and financial results. Twist Bioscience Corporation denies any wrongdoing and the court made no finding of liability.

A $17,050,000.00 settlement of a securities class action brought by investors who bought or acquired Twist Bioscience common stock in its December 2020 Offering or between December 20, 2018 and November 15, 2022. If you bought or acquired the stock in that window and were damaged, you may be able to claim a share of the fund with documentation of your trades. The Court still has to decide whether to approve the settlement at a hearing on November 18, 2026.

Who can claim, how much, and by when

How much can you get?

$0.31 per shareTotal fund: $17,050,000.00

When is the claim deadline?

Who is eligible?

All Persons who purchased or otherwise acquired Twist common stock (i) in the December 2020 Offering pursuant to the 2020 Registration Statement, and were damaged thereby; and/or (ii) between December 20, 2018 and November 15, 2022, both inclusive, and were damaged thereby. Defendants, their affiliates, Twist officers and directors and their immediate family members, and certain related persons and entities are excluded.

How do you get paid?

A share of the Net Settlement Fund, which depends on the type and amount of your Twist common stock transactions and the timing of your purchases, acquisitions and sales. If claims are submitted for 100% of the eligible shares, the estimated average recovery is $0.31 per share of Twist common stock, before deduction of Court-approved fees, expenses, and costs; the official site notes these are only estimates.

What proof do you need?

A timely and valid Proof of Claim, submitted online or postmarked no later than November 17, 2026, that properly documents your claim and includes all the documents the form asks for.

Who is administering the settlement?

Simpluris

What is the case number?

5:22-cv-08168-EKL

How do you file a claim?

File your claim on the official site

This information is not a substitute for legal advice.

Verified on . Based on Official Settlement Website — Peters v. Twist Bioscience Corp., et al., Case No. 5:22-cv-08168-EKL (N.D. Cal.) (Simpluris, 2026). See the method.

More settlements you may be able to claim

Also administered by Simpluris

Deadlines closing soonest

See all open settlements